Umeå universitets logga

umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples
Umeå universitet, Medicinska fakulteten, Institutionen för strålningsvetenskaper, Onkologi.ORCID-id: 0000-0002-4759-2643
International Agency for Research on Cancer, World Health Organization, Lyon, France.
International Agency for Research on Cancer, World Health Organization, Lyon, France.
Umeå universitet, Samhällsvetenskapliga fakulteten, Handelshögskolan vid Umeå universitet, Statistik.ORCID-id: 0000-0002-8143-8500
Visa övriga samt affilieringar
2023 (Engelska)Ingår i: Epigenetics, ISSN 1559-2294, E-ISSN 1559-2308, Vol. 18, nr 1, artikel-id 2196759Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Endogenous sex hormones and DNA methylation both play important roles in various diseases. However, their interplay is largely unknown. A deeper understanding of their interrelationships could provide new insights into the pathology of disease development. We, therefore, investigated associations between circulating sex hormones, sex hormone binding globulin (SHBG), and DNA methylation in blood, using samples from 77 men (65 with repeated samples), from the population-based Northern Sweden Health and Disease Study (NSHDS). DNA methylation was measured in buffy coat using the Infinium Methylation EPIC BeadChip (Illumina). Sex hormone (oestradiol, oestrone, testosterone, androstenedione, dehydroepiandrosterone, and progesterone) and SHBG concentrations were measured in plasma using a high-performance liquid chromatography tandem mass spectrometry (LC/MS-MS) method and an enzyme-linked immunoassay, respectively. Associations between sex hormones, SHBG, and DNA methylation were estimated using both linear regression and mixed-effects models. Additionally, we used the comb-p method to identify differentially methylated regions based on nearby P values. We identified one novel CpG site (cg14319657), at which DNA methylation was associated with dehydroepiandrosterone, surpassing a genome-wide significance level. In addition, more than 40 differentially methylated regions were associated with levels of sex hormones and SHBG and several of these mapped to genes involved in hormone-related diseases. Our findings support a relationship between circulating sex hormones and DNA methylation and suggest that further investigation is warranted, both for validation, further exploration and to gain a deeper understanding of the mechanisms and potential consequences for health and disease.

Ort, förlag, år, upplaga, sidor
Taylor & Francis Group, 2023. Vol. 18, nr 1, artikel-id 2196759
Nyckelord [en]
Sex hormones, sex hormone binding globulin, DNA methylation, men, NSHDS
Nationell ämneskategori
Cancer och onkologi
Identifikatorer
URN: urn:nbn:se:umu:diva-205420DOI: 10.1080/15592294.2023.2196759ISI: 000961068800001PubMedID: 36994855Scopus ID: 2-s2.0-85151198554OAI: oai:DiVA.org:umu-205420DiVA, id: diva2:1741443
Forskningsfinansiär
Cancerforskningsfonden i Norrland, AMP 17-866Cancerforskningsfonden i Norrland, AMP 17-856Cancerforskningsfonden i Norrland, AMP 18-915Cancerforskningsfonden i Norrland, AMP 19-967Region Västerbotten, VLL-547711Region Västerbotten, VLL-680921Region Västerbotten, VLL58269Umeå universitet
Anmärkning

Originally included in thesis in manuscript form. 

Tillgänglig från: 2023-03-06 Skapad: 2023-03-06 Senast uppdaterad: 2023-09-05Bibliografiskt granskad
Ingår i avhandling
1. Circulating markers of risk and etiology in colorectal cancer
Öppna denna publikation i ny flik eller fönster >>Circulating markers of risk and etiology in colorectal cancer
2023 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Alternativ titel[sv]
Cirkulerande markörer för risk och etiologi för kolorektal cancer
Abstract [en]

Background: Colorectal cancer is the third most commonly diagnosed cancer in men and women. Worldwide around 2 million individuals are diagnosed each year – a number expected to increase as colorectal cancer risk factors become more prevalent. In men and women there is a difference in incidence, which possibly could be explained by inherent differences, including sex hormone profiles. The prognosis of colorectal cancer is highly dependent on the stage at diagnosis, with individuals diagnosed at early stages having the best long-term survival. However, as onset of symptoms can be diffuse, many individuals are diagnosed at later stages when survival rates are significantly poorer. Therefore, screening and prevention strategies to detect colorectal cancer at earlier stages or remove cancer precursors such as polyps may be key to increasing survival. Commonly used screening tools today include fecal blood tests and colonoscopy, but they have modest accuracy or may not be cost-effective. Being able to identify markers in blood, either for early detection, as a complementary or alternative screening method, or for risk stratification, could aid in solving this problem. 

Aim: The overall of aim of the thesis was to improve our understanding of underlying factors contributing to CRC etiology and to find biomarkers associated with CRC that could aid in the future development of effective risk prediction models. 

Methods: All studies included in this thesis were based on a case-control cohort nested within the Northern Sweden Health and Disease Study (NSHDS). Additionally in paper I, we also used data from the European Prospective Investigation into Cancer and Nutrition (EPIC), a large multi-center cohort study. In this paper we examined associations between sex hormones, sex hormone binding globulin (SHBG), and colon cancer in men. The study included 690 colon cancer cases and 690 matched controls. Paper II was a longitudinal study, using repeated samples from 80 men, on circulating sex hormones, SHBG, and DNA methylation in white blood cells. Papers III and IV were nested case-control studies on proteins and colorectal cancer risk with Paper III divided into a discovery and a validation phase. In the first phase, which included 69 colorectal cancer case-control pairs with repeated samples, 160 unique proteins related to inflammation and oncology were analyzed. In the second phase, 13 proteins that were significantly associated with colorectal cancer risk, together with 8 proteins identified from the literature, were measured on a custom panel, and validated in a larger material consisting of 1000 case-control pairs. In paper IV, which included 195 colorectal cancer case-control pairs, the protein analysis was extended to include 1536 proteins linked to oncology, inflammation, neurology, and metabolism. In papers using a matched case-control design, conditional i logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CI) for the associations. For longitudinal analyses, mixed effects models were used to estimate associations. 

Results: In paper I, we observed a statistically significant inverse association between circulating levels of testosterone and colon cancer. For SHBG there was a statistically significant inverse association prior to adjustment of testosterone and estradiol levels. In paper II, we found one novel genome-wide significant association between circulating levels of dehydroepiandrosterone and DNA methylation at the cg14319657 CpG site. In addition, we also identified more than 40 differentially methylated regions associated with levels of sex hormones and SHBG. In paper III, we first identified 13 proteins associated with CRC risk in the discovery phase. In the validation phase, however, none of the proteins remained significantly associated with colorectal cancer. When stratifying by tumor site, FGF-21 and PPY, were statically significant in colon and rectal cancer respectively, and showed some modest increase in predictive performance. In paper IV, we identified 20 proteins surpassing a significance threshold of 0.005. One protein, TFF3 (Trefoil Factor 3), which was positively associated with colorectal, also withstood strict Bonferroni correction. In addition, we validated several proteins, including AREG, CEA, and LGALS4, which were identified as biomarker candidates in previous studies. 

Conclusions: Our results support the hypothesis that circulating sex hormones play a role in male colon cancer etiology and that this may partly explain the difference in colorectal cancer incidence between men and women. Furthermore, our findings suggest a possible link between circulating sex hormones, SHBG and DNA methylation, which could be of interest in the etiology of colorectal cancer as well as other hormone-dependent diseases. Finally, we also identified several proteins associated with colorectal cancer, some of which have shown potential as screening markers. 

Ort, förlag, år, upplaga, sidor
Umeå: Umeå University, 2023. s. 60
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 2232
Nyckelord
Colorectal cancer, CRC, sex hormones, colon cancer, DNA methylation, proteomics, risk, etiology
Nationell ämneskategori
Cancer och onkologi
Forskningsämne
cancerepidemiologi
Identifikatorer
urn:nbn:se:umu:diva-205431 (URN)978-91-8070-006-1 (ISBN)978-91-8070-005-4 (ISBN)
Disputation
2023-03-31, Betula, Byggnad 6M, NUS, Umeå, 09:00 (Engelska)
Opponent
Handledare
Tillgänglig från: 2023-03-10 Skapad: 2023-03-06 Senast uppdaterad: 2023-03-13Bibliografiskt granskad

Open Access i DiVA

fulltext(1206 kB)117 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 1206 kBChecksumma SHA-512
ff53b3cd11af719730d482f1286cc6e1e2e86ccf4eaca12c8f9b6387ad9587a7c4a2b43af55562fbf77ed3dc2cb9132b2e024377a106e937a4f63ce8f78ac7de
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Harbs, JustinLiu, XijiaPalmqvist, Richardvan Guelpen, BethanyHarlid, Sophia

Sök vidare i DiVA

Av författaren/redaktören
Harbs, JustinLiu, XijiaPalmqvist, Richardvan Guelpen, BethanyHarlid, Sophia
Av organisationen
OnkologiStatistikPatologiWallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
I samma tidskrift
Epigenetics
Cancer och onkologi

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 117 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 260 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf